Cns Pharmaceuticals Inc [NASDAQ: CNSP] stock went on an upward path that rose over 5.22% on Friday, amounting to a one-week price increase of more than 7.05%.
Over the last 12 months, CNSP stock dropped by -99.79%. The one-year Cns Pharmaceuticals Inc stock forecast points to a potential upside of 76.0. The average equity rating for CNSP stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $7.44 million, with 57.49 million shares outstanding and 56.89 million shares in the current float. Compared to the average trading volume of 16.70M shares, CNSP stock reached a trading volume of 37863918 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Cns Pharmaceuticals Inc [CNSP]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CNSP shares is $0.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CNSP stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Cns Pharmaceuticals Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on December 28, 2020. While these analysts kept the previous recommendation, Ladenburg Thalmann raised their target price to Buy. The new note on the price target was released on August 24, 2020, representing the official price target for Cns Pharmaceuticals Inc stock.
The Average True Range (ATR) for Cns Pharmaceuticals Inc is set at 0.01 The Price to Book ratio for the last quarter was 1.23, with the Price to Cash per share for the same quarter was set at 0.12.
CNSP Stock Performance Analysis:
Cns Pharmaceuticals Inc [CNSP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.05. With this latest performance, CNSP shares gained by 18.73% in over the last four-week period, additionally sinking by -89.92% over the last 6 months – not to mention a drop of -99.79% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CNSP stock in for the last two-week period is set at 58.97, with the RSI for the last a single of trading hit 66.85, and the three-weeks RSI is set at 48.62 for Cns Pharmaceuticals Inc [CNSP]. The present Moving Average for the last 50 days of trading for this stock 0.1164, while it was recorded at 0.1172 for the last single week of trading, and 3.6319 for the last 200 days.
Insight into Cns Pharmaceuticals Inc Fundamentals:
Cns Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.81 and a Current Ratio set at 1.81.
Cns Pharmaceuticals Inc [CNSP] Institutonal Ownership Details
There are presently around $0.79%, or 0.80%% of CNSP stock, in the hands of institutional investors.
